Identification
Instrument name
ASIT Biotech
Symbol
ASIT
ISIN code
BE0974289218
Exchange / Market
Euronext
Trading location
Brussels
Paris
Products family
Stocks
Market organization
EuronextBrussels
ICB
Biotechnology
Website address
http://www.asitbiotech.com
Operation
IPO date
IPO price
EUR 7.00
Catégorie
IPO
Price range
EUR 7.00 - EUR 8.50
Capital raised
23.5

Company profile

ASIT biotech SA specializes in the research and development of immunotherapeutic products for allergy treatment.

Source: Cofisem - Last Update: 30 Aug 2019
Key Executives
Chief Executive Officer Michel Baijot
Company Secretary Grégory Nihon
Chief Financial Officer Frank Hazevoets
Human Resources Director Vincent Theunissen
Source: Cofisem - Last Update: 30 Aug 2019
Key figures
Millenium 2018 2017 2016 2015 2014
Net sales 4 5
Income from ordinary activities 4 8
Operating income -12,767 -11,976 -12,278 -7,640 -4,318
Cost (net) of financial indebtedness 6 -54 -71
Equity-accounted companies' contribution to results
Net profit from discontinued activities
Net income -14,321 -11,986 -12,339 -7,715 -4,429
Net income (Group share) -14,321 -11,986 -12,339 -7,715 -4,429
Fiscal year end 12.18 12.17 12.16 12.15 12.14
Length of fiscal year (month) 12 12 12 12 12
Currency & Unit EUR - thousands EUR - thousands EUR - thousands EUR - thousands EUR - thousands
Account Standards
Source: Cofisem - Last Update: 30 Aug 2019
Shareholder information
Flottant 57.00 %
Rodolphe Spoelberch 9.90 %
SFPI 8.00 %
Société Régionale d'Investissement de Wallonie 6.00 %
Meusinvest 6.00 %
Société Régionale d'Investissements de Bruxelles 5.00 %
Epimède 4.10 %
Managers and Directors 4.00 %
Source: Cofisem - Last Update: 08 Jul 2019